FI822813L - Nya farmaceutiska blandningar - Google Patents

Nya farmaceutiska blandningar

Info

Publication number
FI822813L
FI822813L FI822813A FI822813A FI822813L FI 822813 L FI822813 L FI 822813L FI 822813 A FI822813 A FI 822813A FI 822813 A FI822813 A FI 822813A FI 822813 L FI822813 L FI 822813L
Authority
FI
Finland
Prior art keywords
carbon atoms
group
oc2h5
och3
formula
Prior art date
Application number
FI822813A
Other languages
English (en)
Other versions
FI822813A0 (fi
Inventor
Enar Ingemar Carlsson
Haokan Sigurd Larsson
Wittken Sundell Gunhild Wi Von
Ulf Krister Junggren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI822813A0 publication Critical patent/FI822813A0/fi
Publication of FI822813L publication Critical patent/FI822813L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI822813A 1981-08-13 1982-08-12 Nya farmaceutiska blandningar FI822813L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8104811 1981-08-13

Publications (2)

Publication Number Publication Date
FI822813A0 FI822813A0 (fi) 1982-08-12
FI822813L true FI822813L (fi) 1983-02-14

Family

ID=20344360

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822813A FI822813L (fi) 1981-08-13 1982-08-12 Nya farmaceutiska blandningar

Country Status (27)

Country Link
US (1) US4746667A (fi)
EP (1) EP0074341B1 (fi)
JP (1) JPS5839622A (fi)
KR (1) KR880001714B1 (fi)
AT (1) ATE18765T1 (fi)
AU (1) AU556736B2 (fi)
CA (1) CA1226223A (fi)
CS (1) CS249124B2 (fi)
CY (1) CY1450A (fi)
DD (1) DD202876A5 (fi)
DE (1) DE3270116D1 (fi)
DK (1) DK362482A (fi)
ES (3) ES8401482A1 (fi)
FI (1) FI822813L (fi)
GR (1) GR76267B (fi)
HK (1) HK2189A (fi)
HU (1) HU190408B (fi)
IE (1) IE54215B1 (fi)
IL (1) IL66340A (fi)
IS (1) IS1360B6 (fi)
MY (1) MY8700139A (fi)
NO (1) NO822686L (fi)
NZ (1) NZ201538A (fi)
OA (1) OA07182A (fi)
PH (1) PH18635A (fi)
PT (1) PT75420B (fi)
ZA (1) ZA825106B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
CA1259070A (en) * 1983-07-01 1989-09-05 Upjohn Company (The) Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
JO1406B1 (en) * 1984-11-02 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Chemical compounds
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
AR243167A1 (es) * 1985-08-24 1993-07-30 Hoechst Ag Procedimiento para la preparacion de toluidinas sustituidas.
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
EP0786461A1 (en) * 1986-11-13 1997-07-30 Eisai Co., Ltd. Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
JP2718945B2 (ja) * 1987-06-17 1998-02-25 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
US5223515A (en) * 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
AT394368B (de) * 1990-08-07 1992-03-25 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von 3,4-dialkoxypyridinen
CA2136993A1 (en) * 1992-06-01 1993-12-09 Takeshi Kawakita Pyridine compound and pharmaceutical use thereof
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
EP0729957A4 (en) * 1993-10-29 1996-12-27 Yoshitomi Pharmaceutical PYRIDINE COMPOUND AND ITS USE AS A REMEDY
EP0788795B1 (en) * 1994-06-10 2002-11-13 Nauchno-Issledovatelsky Institut Farmakologii Akademii Meditsinskikh Nauk Pharmacologically active 2-mercaptobenzimidazole derivatives
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
CA2787378C (en) 2004-09-13 2015-11-03 Takeda Pharmaceutical Company Limited Method for producing lansoprazole crystal
EP2003130B1 (en) 2006-03-10 2011-11-16 aRigen Pharmaceuticals, Inc. Novel pyridine derivative having anti-helicobacter pylori activity
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
SI2103608T1 (sl) 2006-12-18 2012-12-31 Arigen Pharmaceuticals, Inc. Sredstvo za eradikacijo Helicobacterja pylori z inhibitorno aktivnostjo za izločanje želoldčne kisline
WO2009105568A1 (en) 2008-02-20 2009-08-27 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
WO2010116740A1 (ja) 2009-04-09 2010-10-14 アリジェン製薬株式会社 ピリジンチオ誘導体及びそれを含有する抗ヘリコバクター・ピロリ作用を有する医薬組成物
US8992897B2 (en) * 2010-01-06 2015-03-31 Elc Management Llc Skin lightening compositions
US8722026B2 (en) * 2010-01-06 2014-05-13 Elc Management, Llc Skin lightening compositions
AU2013267022B2 (en) * 2010-01-06 2016-04-21 Elc Management Llc Skin lightening compositions
JP7029129B2 (ja) * 2016-09-14 2022-03-03 ユーフェン ジェーン ツェン Ｄ－アミノ酸オキシダーゼ（ｄａａｏ）阻害剤としての新規な置換ベンゾイミダゾール誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112208A (fi) * 1971-09-04 1973-03-06
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (fi) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
OA07182A (fr) 1984-04-30
PH18635A (en) 1985-08-23
IE821940L (en) 1983-02-13
JPH0313203B2 (fi) 1991-02-22
ES532044A0 (es) 1984-12-16
NO822686L (no) 1983-02-14
HK2189A (en) 1989-01-20
ES523344A0 (es) 1984-10-01
KR880001714B1 (ko) 1988-09-08
NZ201538A (en) 1985-12-13
GR76267B (fi) 1984-08-04
ES514947A0 (es) 1983-12-16
ES8500265A1 (es) 1984-10-01
DD202876A5 (de) 1983-10-05
DK362482A (da) 1983-02-14
EP0074341B1 (en) 1986-03-26
US4746667A (en) 1988-05-24
JPS5839622A (ja) 1983-03-08
KR840001156A (ko) 1984-03-28
PT75420B (en) 1986-12-09
CY1450A (en) 1989-03-10
ZA825106B (en) 1983-04-27
ES8401482A1 (es) 1983-12-16
IS2749A7 (is) 1983-02-14
MY8700139A (en) 1987-12-31
IE54215B1 (en) 1989-07-19
CA1226223A (en) 1987-09-01
DE3270116D1 (en) 1986-04-30
HU190408B (en) 1986-09-29
IL66340A (en) 1986-08-31
FI822813A0 (fi) 1982-08-12
CS249124B2 (en) 1987-03-12
AU556736B2 (en) 1986-11-20
IS1360B6 (is) 1989-05-25
ES8502109A1 (es) 1984-12-16
AU8697882A (en) 1983-02-17
EP0074341A1 (en) 1983-03-16
ATE18765T1 (de) 1986-04-15
IL66340A0 (en) 1982-11-30
PT75420A (en) 1982-09-01

Similar Documents

Publication Publication Date Title
FI822813A0 (fi) Nya farmaceutiska blandningar
IL71664A (en) Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
AR015769A1 (es) Derivados de imidazo piridina que inhiben la secrecion de acido gastrico, procedimiento para la preparacion de dichos derivados, composicion farmaceutica, uso de dichos derivados para la preparacion de medicamentos, y compuestos intermediarios.
DE2960820D1 (en) Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
IL71788A0 (en) Pyridazinones,processes for their preparation and pharmaceutical compositions containing the same
IL48453A (en) Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
ES8305336A1 (es) "un metodo de preparar una 4-ariloxi-1,2,3,4-tetrahidroisoquinoleina".
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
JPS5432468A (en) Pyrrole derivatives
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
ES483387A1 (es) Procedimiento para la preparacion de 7-fenil-1,4-benzodiaze-pinas, condensadas en (1,2)
IL70272A (en) Acridanone(2-thiazolyl)-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
JPS5246085A (en) Preparation of 3-amino-4-hydroxycarbostyrils
JPS5246083A (en) Preparation of 3-amino-4-hyaroxycarbostyrils
JPS53119825A (en) 1,3-dithioallophanate derivatives, their preparation, insecticides, acaricides, and bactericides for agricultural and horticultural uses
JPS5246084A (en) Preparation of 4-hydroxycarbostyril derivatives

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AKTIEBOLAGET HAESSLE